76
Participants
Start Date
May 23, 2021
Primary Completion Date
November 20, 2022
Study Completion Date
November 20, 2022
Methylprednisolone sodium succinate 10 mg/kg intravenously
Methylprednisolone sodium succinate 10 mg/kg intravenously once daily for 3 days (max 1 g per dose)
Human normal immunoglobulin (IVIg)
Human normal immunoglobulin (IVIg) 2g/kg intravenously as a single dose in line with guidance for dosing and administration in Kawasaki disease
Department of Pediatrics, Cantonal Hospital Fribourg, Villars-sur-Glâne
Department of Pediatrics, University of Bern, Bern
University of Basel Children's Hospital, Basel
Cantonal Hospital Aarau, Department of Paediatrics, Aarau
Department of Pediatrics, Cantonal Hospital Luzern, Lucerne
Ente Ospedaliero Cantonale Ticino (EOC) Pediatrica, Bellinzona
University Children's Hospital Zuerich, Zurich
Children's Hospital of Eastern Switzerland, Sankt Gallen
Department of Child, Woman and, Adolescent Medecine, Geneva University Hospitals and Faculty of Medicine, Geneva
Department of Pediatrics,University Hospital of Lausanne (CHUV), Lausanne
SwissPedNet
UNKNOWN
University Children's Hospital Basel
OTHER